Arcadia Biosciences, Inc. (RKDA) Stock Overview
Explore Arcadia Biosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Arcadia Biosciences, Inc. (RKDA)
Key Financials
Key Financials
Market Cap
974.8K
P/E Ratio
-0.09
EPS (TTM)
$-2.45
ROE
-2.19%
RKDA Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Arcadia Biosciences, Inc. (NASDAQ: RKDA) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Arcadia Biosciences, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of RKDA on the NASDAQ shows an RSI of 37.59, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.
Key metrics behind Arcadia Biosciences, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.09 and a market capitalization of 974.8K. Combined with our AI analysis, these give both institutional and retail investors a clear view of RKDA on the NASDAQ.